249 related articles for article (PubMed ID: 32779081)
1. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
Chamie K; Golla V; Lenis AT; Lec PM; Rahman S; Viscusi ER
J Gastrointest Surg; 2021 Jan; 25(1):293-302. PubMed ID: 32779081
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
Schwenk ES; Grant AE; Torjman MC; McNulty SE; Baratta JL; Viscusi ER
Reg Anesth Pain Med; 2017; 42(6):767-777. PubMed ID: 29016552
[TBL] [Abstract][Full Text] [Related]
3. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
4. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
[TBL] [Abstract][Full Text] [Related]
5. Emerging pharmacologic options for treating postoperative ileus.
Kraft MD
Am J Health Syst Pharm; 2007 Oct; 64(20 Suppl 13):S13-20. PubMed ID: 17909271
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
Ouyang R; Li Z; Huang S; Liu J; Huang J
Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
[TBL] [Abstract][Full Text] [Related]
7. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
Streicher JM; Bilsky EJ
J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
[TBL] [Abstract][Full Text] [Related]
8. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
van Malderen K; Halawi H; Camilleri M
Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
[TBL] [Abstract][Full Text] [Related]
9. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
10. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
Sinatra RS
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
[TBL] [Abstract][Full Text] [Related]
11. Alvimopan, a selective peripherally acting mu-opioid antagonist.
Camilleri M
Neurogastroenterol Motil; 2005 Apr; 17(2):157-65. PubMed ID: 15787936
[TBL] [Abstract][Full Text] [Related]
12. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
Kraft MD
Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
[TBL] [Abstract][Full Text] [Related]
13. Current choices--good or bad--for the proactive management of postoperative ileus: A surgeon's view.
Saclarides TJ
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S7-15. PubMed ID: 16597534
[TBL] [Abstract][Full Text] [Related]
14. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
Argoff CE
Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
[TBL] [Abstract][Full Text] [Related]
15. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
Rauck RL
Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review.
Rekatsina M; Paladini A; Drewes AM; Ayob F; Viswanath O; Urits I; Corli O; Pergolizzi J; Varrassi G
Cureus; 2021 Jul; 13(7):e16201. PubMed ID: 34367804
[TBL] [Abstract][Full Text] [Related]
18. Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment.
Huang B; Li M; Klongkumnuankarn P; Mendez RE; Gillespie JC; Stevens DL; Dewey WL; Selley DE; Zhang Y
J Med Chem; 2022 Mar; 65(6):4991-5003. PubMed ID: 35255683
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
